Engflag

Cholinex

Quick links to important sections

Cholinex

Cholinex_FR

Method of action: Analgesic, Anti-Inflammatory, Antipyretic

Treatment option: Pain, Teething Pain, Fever, Dental

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cholinex

What is Cholinex? (Overview and Quick Facts)

Property Description
Active ingredient Choline Salicylate
Form Lozenge (Solid Dosage Form)
Pharmacological class Topical Non-Steroidal Anti-Inflammatory Drug (NSAID)
General purpose Symptomatic relief of local pain and inflammation
Origin Synthetic compound

What Type of Medicine is Cholinex? (Definition and Classification)

Cholinex is an over-the-counter (OTC) oromucosal preparation defined by its sole active pharmaceutical ingredient, Choline Salicylate. This substance is chemically classified as a salicylate derivative and belongs to the family of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), utilized for its localized effects. The Choline Salicylate component is a synthetic compound specifically designed for application to mucosal surfaces. Its classification as a topical NSAID allows for concentrating the medication's anti-inflammatory and analgesic action locally, emphasizing the benefit of direct tissue contact.

Choline Salicylate: Composition and Form for Local Relief

The active component is Choline Salicylate, presented as a single active ingredient product in the form of a flavored lozenge, which is a solid dosage form. The chemical structure is a salt of salicylic acid complexed with choline, a pairing developed to enhance the solubility and absorption of the active entity across the oral cavity's mucosal tissues. The lozenge format is a defining feature of the brand, ensuring the medicine dissolves slowly, optimizing the duration of contact between the active ingredient and the inflamed tissue via the oromucosal route of administration. This specialized delivery is key to targeting temporary discomfort localized to the throat.

General Purpose: Analgesic and Anti-inflammatory Action

The general purpose of this medicine is to provide symptomatic treatment by utilizing a dual mechanism of effect, delivering both local anti-inflammatory action and a distinct local analgesic effect. This combined effect is crucial for addressing the localized discomfort that often accompanies inflammation. By reducing the swelling and simultaneously dulling the sensation of pain in the immediate area, the medication offers a focused approach. This functionality allows the user to target the cause and the symptom simultaneously, differentiating it from simple throat soothers that lack the anti-inflammatory agent.

What side effects are possible with Cholinex?

Possible Side Effects and Safety Information

Adverse Reaction Documentation

The safety profile of Cholinex is primarily defined by its active ingredient, Choline Salicylate, a salicylate derivative classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Official regulatory documents characterize adverse reactions by System-Organ Class (SOC) and frequency classification.

Classification Scope Details
Frequency Classification All documented adverse reactions are typically classified as Not Known, meaning the incidence cannot be estimated from available data, often relying on post-marketing surveillance.
System-Organ Classes Adverse effects are grouped under categories such as Immune System Disorders (e.g., hypersensitivity) and General Disorders and Administration Site Conditions (e.g., local burning sensation).

Noted Adverse Reactions and Constraints

The most frequently referenced adverse reactions include hypersensitivity reactions and localized burning sensation at the site of application. While serious systemic effects are uncommon due to the topical administration, the salicylate nature of the drug dictates specific safety constraints and limitations, which must be observed.

Class-Specific Safety Considerations

Official labeling mandates specific constraints related to the drug's class. The product is generally contraindicated for individuals with known hypersensitivity to salicylates or other NSAIDs. Furthermore, a crucial constraint exists for children and adolescents, particularly those with concurrent viral infections (such as influenza or chickenpox), due to the association between systemic salicylates and the risk of Reye's syndrome. High-level restrictions are also noted for patients with pre-existing conditions where systemic absorption could pose a risk, including bleeding disorders or a history of gastrointestinal ulceration.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Choline Salicylate overdose is defined by the risk of developing Salicylate Toxicity (Salicylism). Due to the potential for severe systemic effects, government health authorities mandate specific emergency responses and management protocols.

Domain Official Regulatory Statements
Documented Manifestations Symptoms of Salicylism include Tinnitus, Nausea, Vomiting, Hyperventilation, Confusion, Lethargy, and High Fever. Physiological findings include acid-base disturbance.
Severe Outcomes Toxicity may progress to Convulsions and Coma. Gastrointestinal Haemorrhage is a documented complication. Reye’s syndrome risk is noted for children and adolescents under 16 with viral illness.
Mandated Actions Patients must seek immediate medical attention for any sign of suggested toxicity. Regulatory guidance also requires contacting a Poison Control Center right away for instructions.

Official Overdose Management:

  • No specific antidote is known; management is based on supportive care and elimination.
  • Procedures like the administration of Activated Charcoal or Gastric Lavage may be utilized to limit further absorption.
  • Enhanced elimination methods, including Urinary Alkalinisation, are described.
  • Vulnerable patients, such as children and the elderly, may require advanced treatment like Haemodialysis at an earlier stage.

Connection to the overall overdose profile: Regulatory documents define the overdose by its known systemic toxicity, requiring that any symptomatic presentation necessitates immediate medical intervention due to the risk of life-threatening outcomes. The prescribed management focuses on limiting absorption and enhancing elimination.

Therapeutic Uses of Cholinex

Use in Acute Oromucosal Discomfort

This medication is commonly used to help with symptoms related to physical discomfort and soreness that manifest during inflammatory episodes in the throat, mouth, and gums. The treatment is indicated for easing symptoms related to inflammatory or irritative states. It is applied in contexts where short-term, symptomatic assistance is needed for conditions involving mouth ulcers, gum irritation (gingivitis), sore spots from dental devices, and common pharyngitis (sore throat). The treatment may assist with managing the intensity of distressing symptoms, and supports the patient during difficult episodes by easing distress.

“This approach is relevant when supportive symptom management is appropriate, particularly for local pain and swelling.”

The medication is applied in addressing conditions involving inflammatory or irritative processes, marked by the physical discomfort of swelling. Applying this treatment may contribute to improved day-to-day comfort by easing symptoms that interfere with daily functioning, which assists with maintaining functional stability.

Quick Fact: Symptomatic Benefit Summary The medicine is relevant across therapeutic areas involving heightened responses, and is considered relevant to provide supportive relief when symptoms interfere with routine activities and general well-being.

Eligibility and Restrictions for Use

Who Can and Cannot Use Cholinex?

The eligibility for using Cholinex (Choline Salicylate) is defined by regulatory guidelines focusing on age, hypersensitivity, and underlying health conditions. The medicine is permitted for use by adults and children 12 years and over under standard labeled conditions.

Contraindications (Must Not Use)

Use is prohibited for certain populations, including:

  • Individuals with known hypersensitivity to salicylates (like aspirin), other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or any product ingredient.
  • Patients with current or recurrent peptic ulceration or stomach bleeding issues.
  • Children and teenagers who have or are recovering from chickenpox or flu-like symptoms due to the serious risk of Reye's syndrome.
  • The medicine is generally prohibited for children under 12 years of age, with some regulators extending this restriction to those under 16 years.

Restrictions and Conditional Use

Consultation with a health professional is necessary for:

  • Women who are pregnant, particularly during the last three months, or who are breastfeeding.
  • Patients aged 60 and over or those with certain chronic conditions, including high blood pressure, heart disease, asthma, liver disease, or kidney disease.
  • Patients taking blood-thinning (anticoagulant) or steroid medications.

What should I know about interactions with other medicines?

The official regulatory profile for Cholinex (Choline Salicylate) is defined by its classification as a salicylate derivative, which carries recognized risks for systemic interaction despite the topical application. The following interaction patterns and restrictions are based on official government drug labeling.

Documented Interaction Restrictions

Category Interacting Substances Regulatory Statement
Contraindications Acetylsalicylic Acid (Aspirin) and other Salicylates Not to be co-administered, except under the direction of a qualified practitioner.
Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Co-administration is prohibited.
Pharmacodynamic Risk Anticoagulants The salicylate component may enhance the therapeutic effect of these medicines.
Uricosurics The salicylate component may inhibit the therapeutic action of these agents.

Population-Specific Constraints

Regulatory documents define specific constraints for use related to interaction risks. The medicine is contraindicated for use in children and adolescents under 16 years of age. This restriction is mandatory due to the association between salicylates and the potential risk of Reye's syndrome in this population, particularly when viral infections are present. Furthermore, the medicine is contraindicated for use in patients who are currently suffering from active peptic ulceration, reflecting the known gastrointestinal risks associated with systemic exposure to salicylates.

Mechanism of Action

How Cholinex Works

Cholinex's action is governed by its active component, the salicylate ion, which modulates local pain and inflammatory processes at the molecular level through a precise, localized mechanism.

Suppression of Prostaglandin Synthesis via COX-2

The primary mechanism involves targeting the Cyclooxygenase-2 ( COX-2) enzyme, which is a key molecular structure in the production of inflammatory mediators. The drug acts as a suppressor of COX-2 gene expression and activity , decreasing the local concentration of chemicals such as PGE2, which are mediators of inflammatory processes and peripheral nociception. This suppression of the Prostaglandin Biosynthesis Pathway initiates the physiological modulation of inflammation and nociception.

Localized Nociceptor and Tissue Modulation

The reduction in PGE2 concentration alters the sensitivity of the peripheral nociceptive signaling pathway in the oral mucosa. By limiting the chemical sensitization of local pain receptors, the mechanism contributes to the regulation of afferent neural signaling. Furthermore, this mechanism limits mediator-driven vasodilation and vascular permeability, resulting in modulation of localized tissue fluid accumulation.

Formulation and Mechanism Localization

The drug is delivered as the choline salicylate salt in a lozenge, a formulation that enhances the solubility and rapid absorption of the active ingredient across the mucosal surface. This specialized delivery ensures the mechanism remains highly localized, facilitating the delivery of the salicylate ion to the local COX-2 targets, which is consistent with a focused peripheral effect.

Dosage and Administration Information

The administration of Cholinex (150 mg Choline Salicylate lozenge) is structured to ensure targeted local delivery of the active agent, governing the method, frequency, and duration of use.

The Route of Administration is oromucosal, which requires the lozenge to be sucked slowly until fully dissolved. This procedural step is essential to maximize contact time between the topical agent and the affected tissues, aligning with the principles for local oral drug forms. The lozenge can be administered independently of meals.

Dosing and Age Rules

The Dosing Regimen establishes precise limits based on age and is designated for short-term use only. Adults and adolescents 12 years of age and older are typically directed to take 1 lozenge (150 mg Choline Salicylate) per dose. The administration schedule is 4 to 6 times a day, with a maximum daily dose of six lozenges (900 mg).

Use in children aged 6 to 12 years requires a modified schedule, limiting the intake to a maximum of four lozenges (600 mg) per 24 hours. The product label generally does not recommend use for children younger than six years of age.

Duration Constraint

A key procedural constraint is the duration limit: administration is limited to a short period. Users are directed to seek professional medical consultation if symptoms persist or worsen after 1 to 2 days of continuous use, confirming its designation as a limited-duration, symptomatic treatment.

Recent Clinical Evidence

Cholinex contains choline salicylate, an active ingredient that has been studied in various clinical contexts, primarily for its local anti-inflammatory and analgesic (pain-relieving) properties when used in the oral cavity and throat.

Overview of Efficacy Research

Research has investigated the study parameters for changes in pain levels and the duration of symptoms associated with throat irritation and inflammation. Studies evaluated whether there was a difference in the measured duration of symptoms between participants who received the study treatment and those who received a placebo. Clinical trials have primarily compared outcomes against a placebo over short-term observation periods.

Mechanism of Action Studies

Research has investigated the drug's interaction with the body. As a salicylate derivative, it is understood to be related to the class of non-steroidal anti-inflammatory drugs (NSAIDs). Studies investigated the measurement of biomarkers of inflammation, such as C-reactive protein (CRP), in blood samples taken before and after treatment administration, looking at the timeframe of any reported measurements in the body’s inflammatory response.

Safety and Tolerability Profiles

Research examined the drug’s profile in various populations, focusing on short-term use. Studies have collected reports of participant experiences to understand its tolerability. Due to the nature of the active ingredient, specific studies have also evaluated whether the study treatment, when administered alongside commonly used antibiotics, was associated with measurements in the levels of either substance in the bloodstream.

Research scope was typically defined up to a short-term period, and evidence regarding long-term use is generally limited beyond initial observation.

Frequently Asked Questions (FAQ)

Common questions about Cholinex (FAQ)

Q: What should I do if my sore throat doesn't get better after taking Cholinex?

Cholinex is designated for short-term, symptomatic relief. Official product information states that if symptoms persist or worsen after 1 to 2 days of continuous use, it is recommended to seek professional medical consultation. This step is advised to allow for a professional review of your symptoms.

Q: What is the specific age limit for children to use Cholinex?

Official dosing guidelines state that the product is generally not recommended for children younger than six years of age. Separately, regulatory documents indicate use is contraindicated (prohibited) for children and adolescents under 16 years of age who have or are recovering from viral infections, due to the recognized risk of Reye's syndrome associated with salicylates.

Q: What are the common side effects of Cholinex?

According to official product information, the most frequently referenced adverse reactions are a localized burning sensation at the site of application and hypersensitivity reactions, which involve allergic-type symptoms. Regulatory documents often classify the incidence of adverse reactions as 'Not Known,' meaning the frequency cannot be estimated from the available data.

Q: What's the right way to take the Cholinex lozenge?

The lozenge is intended for oromucosal (in the mouth) use, which ensures the local delivery of the medicine. Official product information states that the lozenge is to be sucked slowly until it is fully dissolved. The specific dosing and frequency for adults is detailed in the 'How to Use' section of the product labeling.

Q: What should I do if I accidentally take too many Cholinex lozenges?

If an overdose is suspected, official product information advises seeking medical assistance immediately. The product documentation outlines the symptoms that may occur and the general recommendation to contact a healthcare professional or emergency services as soon as possible.

How should Cholinex be stored and disposed of?

How to Store and Dispose of Cholinex (Choline Salicylate Lozenge)

Official regulatory guidelines define specific storage and disposal requirements for Cholinex to maintain product stability and ensure safety.

Storage Requirements

Condition Requirement
Temperature Store at or below 25 C to protect the solid dosage form from heat.
Protection Must be protected from moisture and kept in the original container or packaging (e.g., blister strip).
Safety Keep out of the sight and reach of children to prevent accidental access.

Disposal Instructions

Do not use the lozenges after the labeled expiry date. Disposal of any unused or expired Cholinex must be done responsibly. Do not throw away the medicine via wastewater or household waste. The medicine must be discarded in accordance with local requirements, typically by returning it to a pharmacy or designated collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagPoland

flagRomania

Equivalent of Cholinex found in:

A-Z Index: